The Kiel University, officially the Christian-Albrecht University of Kiel, is a university in the city of Kiel, Germany. It was founded in 1665 as the Academia Holsatorum Chiloniensis by Christian Albert, Duke of Holstein-Gottorp and has approximately 27,000 students today.

During the past decade, University of Kiel conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kiel" #1 sponsor was "AGO Study Group" with 3 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "BioCryst Pharmaceuticals" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Heidelberg University" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kiel" #1 collaborator was "ApoPharma" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Kiel" are "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Crohn's Disease" (2 trials), "Parkinson Disease" (2 trials) and "Anaplastic Astrocytoma" (1 trials). Many other conditions were trialed in "University of Kiel" in a lesser frequency.

Most popular intervention types in "University of Kiel" are "Drug" (13 trials), "Device" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "Placebo" (2 trials), "Semapimod" (2 trials), "paclitaxel" (2 trials) and "1. Tesofensine (NS 2330)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Kiel" are 13 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Kiel". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University of Kiel, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kiel, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

University of Kiel has several departments that took part in Clinical trials: "Universitäts-Hautklinik Kiel" - 7 trials, "University of Schleswig-Holstein, Campus Kiel, Department of Nephrology" - 5 trials, "University Hospital Kiel - Dep. of. Anesthesiology and Intensive Care Medicine" - 4 trials, "Medical Department II, University Hospital of Kiel" - 4 trials, "Department of Neurology" - 2 trials, "University Childrens Hospital" - 2 trials